4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-019987
Chief Product Strategy Officer gave up 753 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kieffer Tara Lynn Chief Product Strategy Officer | 2024-12-01 | Shares withheld for taxes | −753 | $8.60 | $6,476 | 31,588 | D |
Loading xslF345X05/form4.xml…